Moshe Vardi, MD
Adjunct Assistant Professor
Boston University School of Public Health
Dept of Biostatistics

MD, Tel Aviv University (TAU)




Dr. Vardi is a Global Clinical Development Lead at Shire, previously a Clinical Research Medical Advisor at Novartis, the Medical Director at the Harvard Clinical Research Institute (HCRI), and an Assistant Professor (adj) at the Boston University School of Public Health (BUSPH). Dr. Vardi has a wide range of clinical, scientific and clinical research experience in diverse therapeutic indications, with involvement on both scientific and operational aspects. His current main focus is in the rare disease space, and prior to that in the cardio-metabolic space, with a footprint in design, execution, summary of results and submission to health agencies. His career in the field also includes a position as an Acting Director of an Internal Medicine unit, and board member of several national and international societies and professional working groups, and 15 years of experience in the Medical Device and Pharma industry. Dr. Vardi is a recipient of the European Federation of Internal Medicine Honorary Fellow award (2011). His research has been published in leading, peer-reviewed scientific journals, and has served as an Associate Editor for the European Journal of Internal Medicine.

2011 Honorary Fellowship of the European Federation of Internal Medicine
2009 Technion- Israeli Institute of Technology, Haifa, Israel: Excellence in Teaching Award, Faculty of Medicine

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Girolami A, Rolland C, Sexton D, Vardi M, Bernstein JA. Long-term safety outcomes of prekallikrein (Fletcher factor) deficiency: A systematic literature review of case reports. Allergy Asthma Proc. 2020 01 17; 41(1):10-18. PMID: 31888778
     
  2. Fukunaga A, Morita E, Miyagi T, Eto K, Shimizu A, Kagami S, Yamamoto H, Vardi M, Tang Y, Wang Y, Hide M. [EFFICACY, PHARMACOKINETICS, PHARMACODYNAMICS, AND SAFETY OF INTRAVENOUS C1 INHIBITOR FOR LONG-TERM PROPHYLAXIS AND TREATMENT OF BREAKTHROUGH ATTACKS IN JAPANESE SUBJECTS WITH HEREDITARY ANGIOEDEMA: A PHASE 3 OPEN-LABEL STUDY]. Arerugi. 2020; 69(3):192-203. PMID: 32435020
     
  3. Hide M, Fukunaga A, Maehara J, Eto K, Hao J, Vardi M, Nomoto Y. Efficacy, pharmacokinetics, and safety of icatibant for the treatment of Japanese patients with an acute attack of hereditary angioedema: A phase 3 open-label study. Allergol Int. 2020 Apr; 69(2):268-273. PMID: 31672405
     
  4. Girolami A, Rolland C, Sexton D, Vardi M, Bernstein JA. Long-term safety outcomes of prekillikrein (Fletcher factor) deficiency: A systematic literature review of case reports. Allergy Asthma Proc. 2019 Sep 17. PMID: 31530337
     
  5. Aygören-Pürsün E, Soteres DF, Nieto-Martinez SA, Christensen J, Jacobson KW, Moldovan D, Van Leerberghe A, Tang Y, Lu P, Vardi M, Schranz J, Martinez-Saguer I. A randomized trial of human C1 inhibitor prophylaxis in children with hereditary angioedema. Pediatr Allergy Immunol. 2019 08; 30(5):553-561. PMID: 30968444
     
  6. Lumry WR, Martinez-Saguer I, Yang WH, Bernstein JA, Jacobs J, Moldovan D, Riedl MA, Johnston DT, Li HH, Tang Y, Schranz J, Lu P, Vardi M, Farkas H. Fixed-Dose Subcutaneous C1-Inhibitor Liquid for Prophylactic Treatment of C1-INH-HAE: SAHARA Randomized Study. J Allergy Clin Immunol Pract. 2019 May - Jun; 7(5):1610-1618.e4. PMID: 30682573
     
  7. Hide M, Fukunaga A, Maehara J, Eto K, Hao J, Vardi M, Nomoto Y. [EFFICACY, PHARMACOKINETICS, AND SAFETY OF ICATIBANT FOR THE TREATMENT OF JAPANESE PATIENTS WITH AN ACUTE ATTACK OF HEREDITARY ANGIOEDEMA: A PHASE 3 OPEN-LABEL STUDY]. Arerugi. 2018; 67(2):139-147. PMID: 29553114; DOI: 10.15036/arerugi.67.139;
     
  8. Muady GF, Bitterman H, Laor A, Vardi M, Urin V, Ghanem-Zoubi N. Hemoglobin levels and blood transfusion in patients with sepsis in Internal Medicine Departments. BMC Infect Dis. 2016 10 13; 16(1):569. PMID: 27737630; DOI: 10.1186/s12879-016-1882-7;
     
  9. Ghanem-Zoubi N, Bitterman H, Laor A, Yurin V, Vardi M. The accuracy of clinical prediction of prognosis for patients admitted with sepsis to internal medicine departments. Ann Med. 2015; 47(7):555-60. PMID: 26426517; DOI: 10.3109/07853890.2015.1089361;
     
  10. Vardi M, Cryer BL, Cohen M, Lanas A, Schnitzer TJ, Lapuerta P, Goldsmith MA, Laine L, Doros G, Liu Y, McIntosh AI, Cannon CP, Bhatt DL. The effects of proton pump inhibition on patient-reported severity of dyspepsia when receiving dual anti-platelet therapy with clopidogrel and low-dose aspirin: analysis from the Clopidogrel and the Optimization of Gastrointestinal Events Trial. Aliment Pharmacol Ther. 2015 Aug; 42(3):365-74.View Related Profiles. PMID: 26032114; PMCID: PMC4494867; DOI: 10.1111/apt.13260;
     
Showing 10 of 56 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 56 publications over 17 distinct years, with a maximum of 7 publications in 2011

YearPublications
20031
20041
20051
20062
20073
20082
20094
20104
20117
20126
20136
20146
20155
20161
20181
20194
20202

Contact for Mentoring:

801 Massachusetts Avenue
Boston MA 02118
Google Map


Vardi's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department